Wordt geladen...
Denosumab for the Treatment of Osteoporosis
INTRODUCTION: Low trauma fractures due to osteoporosis are a major health concern worldwide. Despite the availability of many therapeutic compounds to reduce fracture risk, osteoporosis remains undertreated and the burden of osteoporotic fractures remains high. Denosumab is a novel agent that acts t...
Bewaard in:
| Gepubliceerd in: | Expert Opin Drug Metab Toxicol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480604/ https://ncbi.nlm.nih.gov/pubmed/25614274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425255.2015.1000860 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|